HY-13894-10mg
|
MedChemexpress LLC
|
Tyrphostin AG1296 [CAS 146535-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-13894-100mg
|
MedChemexpress LLC
|
Tyrphostin AG1296 [CAS 146535-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-13894-25mg
|
MedChemexpress LLC
|
Tyrphostin AG1296 [CAS 146535-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-13894-5mg
|
MedChemexpress LLC
|
Tyrphostin AG1296 [CAS 146535-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-13894-50mg
|
MedChemexpress LLC
|
Tyrphostin AG1296 [CAS 146535-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-13894-1mL
|
MedChemexpress LLC
|
Tyrphostin AG1296 [CAS 146535-11-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-119123-10mg
|
MedChemexpress LLC
|
Voxvoganan [CAS 1166254-80-3]
|
|
COVID-19-immunoregulation
|
|
HY-119123-100mg
|
MedChemexpress LLC
|
Voxvoganan [CAS 1166254-80-3]
|
|
COVID-19-immunoregulation
|
|
HY-119123-25mg
|
MedChemexpress LLC
|
Voxvoganan [CAS 1166254-80-3]
|
|
COVID-19-immunoregulation
|
|
HY-119123-5mg
|
MedChemexpress LLC
|
Voxvoganan [CAS 1166254-80-3]
|
|
COVID-19-immunoregulation
|
|
HY-119123-50mg
|
MedChemexpress LLC
|
Voxvoganan [CAS 1166254-80-3]
|
|
COVID-19-immunoregulation
|
|
HY-136072-10mg
|
MedChemexpress LLC
|
Xeruborbactam (disodium) [CAS 2170848-99-2]
|
|
COVID-19-immunoregulation
|
|
HY-136072-25mg
|
MedChemexpress LLC
|
Xeruborbactam (disodium) [CAS 2170848-99-2]
|
|
COVID-19-immunoregulation
|
|
HY-136072-5mg
|
MedChemexpress LLC
|
Xeruborbactam (disodium) [CAS 2170848-99-2]
|
|
COVID-19-immunoregulation
|
|
HY-136072-50mg
|
MedChemexpress LLC
|
Xeruborbactam (disodium) [CAS 2170848-99-2]
|
|
COVID-19-immunoregulation
|
|